Gene Therapies: On the Rise

<span>Ryan McDonough, PE featured in Pharmaceutical Manufacturing article &quot;Gene therapies: On the rise.&quot; The article written by Meagan Parrish, Senior Editor, takes a look inside the industry&#39;s struggle to produce gene therapies on a higher level. Below is an excerpt from the article: The industry has faced similar challenges before. In fact, several...</span>
Pharmaceutical Manaufacturing

Ryan McDonough, PE featured in Pharmaceutical Manufacturing article "Gene therapies: On the rise."

The article written by Meagan Parrish, Senior Editor, takes a look inside the industry's struggle to produce gene therapies on a higher level.

Below is an excerpt from the article:

The industry has faced similar challenges before. In fact, several experts pointed out that right now, the gene therapy market looks a lot like the market for monoclonal antibodies after they first started hitting the scene. As drug developers worked to transition their process from the lab to the plant, the challenges of scaling up created several stumbling blocks.

“I would see the gene therapy market as being a bit chaotic for the next few years,” McDonough says.

As the industry moves forward, the overarching goal is to create a repeatable platform for gene therapy manufacturing that many companies can replicate. And equipment manufacturers are also working together at an increased rate to innovate new solutions.

“I think the collaboration has been remarkable, especially for the speed at which the market is growing,” McDonough says.

Read the full article here.

Source: www.crbusa.com